Surgical interventions for cancer patients with impending or actual pathologic fractures

Orthopaedic Nursing

Volumn 27, Issue 3, 2008, Pages 160-171

  Johnson, Stacy K ^a   Knobf, M Tish ^b,c  

^a U of MN St Cloud Hospital FMR   (United States)

^b Department of Oncology Nursing ^*

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; BONE REMODELING; BONE TUMOR; CLASSIFICATION; FEMUR FRACTURE; HOSPITALIZATION; HUMAN; METASTASIS; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; ORTHOPEDIC NURSING; PATHOLOGIC FRACTURE; PATIENT EDUCATION; PATIENT SELECTION; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; RISK FACTOR;

BONE NEOPLASMS; BONE REMODELING; FEMORAL FRACTURES; FRACTURES, SPONTANEOUS; HUMANS; MEDICAL HISTORY TAKING; NURSE'S ROLE; NURSING ASSESSMENT; ORTHOPEDIC NURSING; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PERIOPERATIVE CARE; PHYSICAL EXAMINATION; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 51149093101     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/01.NOR.0000320543.90115.d5     Document Type: Article

References (33)

1. American Cancer Society. (2007). Cancer facts and figures (pp. 1-54). Atlanta, GA: Author.
2. Baldwin, P. D. (2003). Thrombocytopenia. Clinical Journal of Oncology Nursing, 7(3), 349-352.
3. Boyajian, R. N., & Noonan, K. A. (2006). Fractures. In D. Camp-Sorrell & R. A. Hawkins (Eds.), Clinical manual for the oncology advanced practice nurse (2nd ed., pp. 733-737). Pittsburgh, PA: Oncology Nursing Society.
4. Buggay, D., & Jaffe, K. (2003). Metastatic bone tumors of the pelvis and lower extremity. Journal of Surgical Orthopaedic Advances, 12(4), 192-199.
5. Coleman, R. E. (2004). Bisphosphonates: Clinical experience. Oncologist, 9(Suppl. 4), 14-27.
6. Damron, T. A., & Ward, W. G. (2003). Risk of pathologic fracture: Assessment. Clinical Orthopaedics and Related Research, 415(Suppl.), S208-S211.
7. Ewing, J. (1928). Metastasis. In J. Ewing (Ed.), Neoplastic diseases a treatise on tumors (3rd ed., pp. 77-89). Philadelphia: W.B. Saunders.
8. Frassica, F. J., Frassica, D.A., Jacofsky D. J., & Sim, F. H. (2002). Palliative orthopedic surgery. In A. M. Berger, R. K. Portenoy, & D. E. Weissman (Eds.), Principles and practice of palliative care and supportive oncology (2nd ed., pp. 722-730). Philadelphia, PA: Lippincott Williams & Wilkins.
9. Getty, P. J., Nielson, J. L., Huff, T., Robbin, M. R., & Overmoyer, B. A. (2006). Metastatic cancer to bone. In A. E. Chang, P. A. Ganz, D. F. Hayes, T. J. Kinsella, H. I. Pass, J. H. Schiller, et al. (Eds.), Oncology an evidence-based approach (pp. 1655-1678). New York: Springer.
10. Habermann, E. T., & Lopez, R. A. (1989). Metastatic disease of bone and treatment of pathological fractures. Orthopedic Clinics of North America, 20(3), 469-486.
11. Harrington, K. D. (1981). The management of acetabular insufficiency secondary to metastatic malignant disease. Journal of Bone and Joint Surgery-Series A, 63(4), 653-664.
12. Harrington, K. D. (1986). Impending pathologic fractures from metastatic malignancy: Evaluation and management. Instructional Course Lectures, 35, 357-381.
13. Harrington, K. D. (1995). Orthopaedic management of extremity and pelvic lesions. Clinical Orthopaedics and Related Research, 312, 136-147.
14. Jacofsky, D. J., & Haidukewych, G. J. (2004). Management of pathologic fractures of the proximal femur: State of the art. Journal of Orthopaedic Trauma, 18(7), 459-469.
15. Lane, J. M., Sculco, T. P., & Zolan, S. (1980). Treatment of pathological fractures of the hip by endoprosthetic replacement. Journal of Bone and Joint Surgery-Series A, 62(6), 954-959.
16. Manabe, J., Kawaguchi, N., Matsumoto, S., & Tanizawa, T. (2005). Surgical treatment of bone metastasis: Indications and outcomes. International Journal of Clinical Oncology, 10(2), 103-111.
17. Mirels, H. (1989). Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clinical Orthopaedics and Related Research, 249, 256-264.
18. Morris, C. D., Sepkowitz, K., Fonshell, C., Margetson, N., Eagan, J., Miransky, J., et al. (2003). Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Annals of Surgical Oncology, 10(7), 778-782.
19. Narazaki, D. K., De Neto Alverga, C. C., Baptista, A. M., Caiero, M. T., & De Camargo, O. P. (2006). Prognostic factors in pathologic fractures secondary to metastatic tumors. Clinics, 61(4), 313-320.
20. Odom-Forren, J. (2006). Preventing surgical site infections. Nursing, 36(6), 58-63.
21. Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 133(3421), 571-573.
22. Reich, C. D. (2003). Advances in the treatment of bone metastases. Clinical Journal of Oncology Nursing, 7(6), 641-646.
23. Roodman, G. D. (2007). Mechanisms of bone metastases. In B. D. Rose (Ed.), UpToDate. Waltham, MA: UpToDate.
24. Rougraff, B. T., Kneisl, J. S., & Simon, M. A. (1993). Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. Journal of Bone and Joint Surgery-Series A, 75(9), 1276-1281.
25. Swanson, K. C., Pritchard, D. J., & Sim, F. H. (2000). Surgical treatment of metastatic disease of the femur. The Journal of the American Academy of Orthopaedic Surgeons, 8(1), 56-65.
26. Strohl, R. A., & Hawkins, R. A. (2006). Bone metastasis. In D. Camp-Sorrell & R. A. Hawkins (Eds.), Clinical manual for the oncology advanced practice nurse (2nd ed., pp. 727-731). Pittsburgh, PA: Oncology Nursing Society.
27. Townsend, P. W., Rosenthal, H. G., Smalley, S. R., Cozad, S. C., & Hassanein, R. E. S. (1994). Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. Journal of Clinical Oncology, 12(11), 2345-2350.
28. Ward, W. G., Holsenbeck, S., Dorey, F. J., Spang, J., & Howe, D. (2003). Metastatic disease of the femur: Surgical treatment. Clinical Orthopaedics and Related Research, 415(Suppl.), S230-S244.
29. Weber, K. L., Lewis, V. O., Randall, R. L., Lee, A. K., & Springfield, D. (2004). An approach to the management of the patient with metastatic bone disease. Instructional Course Lectures, 53, 663-676.
30. Weber, K. L., & O'Connor, M. I. (2003). Operative treatment of long bone metastases: Focus on the femur. Clinical Orthopaedics and Related Research, 415(Suppl.), S276-S278.
31. Weber, K. L., Randall, R. L., Grossman, S., & Parvizi, J. (2006). Management of lower-extremity bone metastasis. Journal of Bone and Joint Surgery-Series A, 88(Suppl. 4), 11-19.
32. Winchester, D. P., Sener, S. F., & Khandekar, J. D. (1979). Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer, 43(3), 956-960.
33. Zeuner, A., Signore, M., Martinetti, D., Bartucci, M., Peschle, C., & De Maria, R. (2007). Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Research, 67(10), 4767-4773.